comscoreBiosimilars: What Are They and What Are Their Advantages?

Biosimilars: What Are They and What Are Their Advantages?

Dr. Philip Lammers explains what a biosimilar drug is and how we can be sure they are safe and effective.
Mar 30, 2017

Dr. Philip Lammers has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies state-of-the art cancer treatments, including biosimilars.

Listen to the podcast to hear Dr. Lammers explain:

  • what a biosimilar drug is, as well as the approval process for biosimilars

  • how we can be sure that biosimilars are as safe as the reference products

  • the advantages and disadvantages of biosimilars

  • when we might see biosimilars on the market to treat breast cancer

About the guest
Philip Lammers, MD, MSCI

Dr. Philip Lammers is a medical oncologist, the chief of the Division of Hematology/Oncology at Meharry Medical College, and adjunct assistant professor of internal medicine at Vanderbilt University.

— Last updated on June 29, 2022, 2:49 PM

Support to produce more content like this

Your donation goes directly to what you read, hear, and see on